Chemoprevention research: implications for primary care practice.
The field of cancer prevention research is entering a time of growth and opportunity. This important research is identifying agents that are making a substantial difference by reducing cancer incidence in high-risk populations. Primary care providers are natural partners for this research because of their diversity, commitment to disease prevention, and long-term access to their patient population. Several national chemoprevention trials in breast and prostate cancer are open and seeking to affiliate with primary care providers. Information is provided on this research effort, the development of chemoprevention trials, and how to learn more.
National Cancer Institute, 31 Center Drive, Bldg. 31, Room 3A44, Bethesda, MD 20892-2440, USA.
A M
AM
Denicoff
R M
RM
Padberg
D000328:Adult; D000368:Aged; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000517:prevention & control*; D002170:Canada; D002986:Clinical Trials as Topic; D004181:Directories as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D011320:Primary Health Care; D011471:Prostatic Neoplasms / Q000517:prevention & control*; D011647:Puerto Rico; D014481:United States
D016588:Anticarcinogenic Agents